Kairos Therapeutics Overview
- Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$18.4M
Kairos Therapeutics General Information
Description
Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform that enables development of therapeutics for the treatment of multiple forms of cancer.
Contact Information
Website
www.kairostherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 2405 Wesbrook Mall
- Fourth Floor
- Vancouver, British Columbia V6T 1Z3
- Canada
Kairos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 18-Mar-2016 | $18.4M | 0000 | Completed | Startup | |
| 1. Early Stage VC | 12-Dec-2013 | Completed | Startup |
Kairos Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform t
Biotechnology
Vancouver, Canada
7
As of 2016
000
0000-00-00
000000&0
000000
iusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exe
0000000000000
La Jolla, CA
0
As of 0000
00.000
000000&0
00.000
000000
minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000000000000
Planegg, Germany
000
As of 0000
00000
000000000
00000
Add Comparison
Kairos Therapeutics Competitors (34)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abreos Biosciences | Formerly VC-backed | La Jolla, CA | 0 | 00.000 | 000000&0 | 00.000 |
| 000000000 | Formerly PE-Backed | Planegg, Germany | 000 | 00000 | 000000000 | 00000 |
| 00000000 | Formerly VC-backed | San Carlos, CA | 00 | 00000 | 000000000 | 00000 |
| 000000 0000000 | Venture Capital-Backed | Zurich, Switzerland | 00 | 000.00 | 000000 0 | |
| 0000000 | Formerly Accelerator/Incubator backed | San Francisco, CA | 0 | 000000&0 |
Kairos Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| John Babcook | Co-Founder, Chief Scientific Officer & President |
Kairos Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kairos Therapeutics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CDRD Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |